12 |
HUMAN INSULIN MARKET, BY REGION.................................................................................... 98 |
||
• 12.1 |
INTRODUCTION............................................................................................................................................................... 99 |
||
• 12.2 |
NORTH AMERICA........................................................................................................................................................... 100 |
||
• 12.2.1 |
U. S............................................................................................................................................................... 103 |
||
• 12.2.2 |
CANADA....................................................................................................................................................... 104 |
||
• 12.3 |
EUROPE.......................................................................................................................................................................... 106 |
||
• 12.3.1 |
GERMANY.................................................................................................................................................... 109 |
||
• 12.3.2 |
FRANCE....................................................................................................................................................... 110 |
||
• 12.3.3 |
U. K............................................................................................................................................................... 112 |
||
• 12.3.4 |
REST OF EUROPE( ROE).............................................................................................................................. 113 |
||
• 12.4 |
ASIA-PACIFIC( APAC).................................................................................................................................................... 115 |
||
• 12.4.1 |
JAPAN.......................................................................................................................................................... 118 |
||
• 12.4.2 |
CHINA.......................................................................................................................................................... 119 |
||
• 12.4.3 |
INDIA............................................................................................................................................................ 120 |
||
• 12.4.4 |
REST OF ASIA-PACIFIC( ROAPAC).............................................................................................................. 122 |
||
• 12.5 |
REST OF THE WORLD( ROW)......................................................................................................................................... 124 |
||
13 |
COMPETITIVE LANDSCAPE..................................................................................................... 126 |
||
• 13.1 |
OVERVIEW...................................................................................................................................................................... 126 |
||
• 13.2 |
MARKET SHARE ANALYSIS........................................................................................................................................... 127 |
||
• 13.2.1 |
HUMAN INSULIN DRUGS MARKET............................................................................................................. 129 |
||
• 13.2.2 |
HUMAN INSULIN DELIVERY DEVICES MARKET......................................................................................... 130 |
||
• 13.3 |
COMPETITIVE SCENARIO.............................................................................................................................................. 131 |
||
• 13.4 |
RECENT DEVELOPMENTS............................................................................................................................................. 132 |
||
• 13.4.1 |
GEOGRAPHICAL EXPANSIONS.................................................................................................................... 132 |
||
• 13.4.2 |
AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS......................................................................... 133 |
||
• 13.4.3 |
NEW PRODUCT LAUNCHES........................................................................................................................ 134 |
||
• 13.4.4 |
AWARENESS PROGRAMS............................................................................................................................ 136 |
||
• 13.4.5 |
FUNDING & SCHOLARSHIPS...................................................................................................................... 137 |
||
• 13.4.6 |
STRATEGIC ACQUISITIONS......................................................................................................................... 138 |
||
• | |||